ストックスクリーナーアプリを入手
16.50
13.72%
-2.625
アフターアワーズ：
16.63
0.125
+0.76%
前日終値:
$19.13
開ける：
$20
24時間の取引高:
5.09M
Relative Volume:
2.15
時価総額：
$2.12B
収益：
$745.97M
当期純損益:
$-99.21M
株価収益率:
-21.35
EPS:
-0.7729
ネットキャッシュフロー:
$-5.09M
1週間 パフォーマンス:
-11.93%
1か月 パフォーマンス:
-5.03%
6か月 パフォーマンス:
+105.80%
1年 パフォーマンス:
+81.37%
1日の値動き範囲:
$16.47
$20.15
1週間の範囲:
$16.47
$20.15
52週間の値動き範囲:
$7.065
$20.15
Neogenomics Inc Stock (NEO) Company Profile
Compare NEO vs TMO, DHR, NTRA, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
16.50 | 2.48B | 745.97M | -99.21M | -5.09M | -0.7729 |
TMO
Thermo Fisher Scientific Inc
|
656.58 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.61 | 150.48B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
400.65 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
169.33 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
436.43 | 42.59B | 3.77B | 449.25M | 240.68M | 7.8556 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-29 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 開始されました | Guggenheim | Neutral |
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance
Zacks Research Downgrades NeoGenomics (NASDAQ:NEO) to Hold - MarketBeat
NeoGenomics stock trades at EUR 17.04 after Q2 EPS beat - AD HOC NEWS
NeoGenomics, Inc. (NEO) stock price, news, quote and history - au.finance.yahoo.com
Is NeoGenomics Inc (NEO) Overvalued After 6.5% Rally? GF Value S - GuruFocus
NeoGenomics (NASDAQ:NEO) Trading 4.8% HigherHere's Why - MarketBeat
NeoGenomics, Inc. (NEO) Stock forecasts - Yahoo Finance Singapore
NeoGenomics stock falls 2.81 percent after Q2 revenue beat - AD HOC NEWS
Precision Oncology Expansion Could Be A Game Changer For NeoGenomics Stock - Simply Wall Street
Liquidity Mapping Around (NEO) Price Events - Stock Traders Daily
NeoGenomics, Inc. (NEO) Stock Analysis: Strong Buy Ratings Amid 11.2% Revenue Growth - DirectorsTalk Interviews
NeoGenomics (NEO) Expands Precision Oncology Focus, Is The Stock Fairly Valued? - Yahoo Finance
Is NeoGenomics’ (NEO) Community NGS Push Quietly Redefining Its Core Earnings Engine? - Yahoo Finance
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference - MarketBeat
NeoGenomics (NEO) Stock Looks Above Fair Value On Current Sales - Simply Wall Street
A Look at NeoGenomics Inc (NEO) After 5.0% Gain -- GF Value $16. - GuruFocus
NeoGenomics (NASDAQ:NEO): What's Behind Its New High? - Kalkine Media
NeoGenomics (NASDAQ:NEO) Sets New 52-Week HighShould You Buy? - MarketBeat
Neogenomics stock hits 52-week high at 19.78 USD By Investing.com - Investing.com Australia
Neogenomics stock hits 52-week high at 19.78 USD - Investing.com
NeoGenomics Q2 2026 Earnings: EPS Beat of 51% Overshadows Revenue SilenceEarnings Trend Analysis - careplusvn.com
NeoGenomics at Morgan Stanley conference: NGS, MRD drive growth By Investing.com - Investing.com Canada
Squarepoint Ops LLC Purchases 120,342 Shares of NeoGenomics, Inc. $NEO - MarketBeat
WINTON GROUP Ltd Purchases New Position in NeoGenomics, Inc. $NEO - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
(NEO) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NEOGENOMICS, INC.COMMON STOCKGilbert Ray Cisneros, Jr. Congressional Trade on Aug. 07, 2026 - Quiver Quantitative
A Look Back at Testing & Diagnostics Services Stocks’ Q2 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack - Yahoo Finance
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
NeoGenomics, Inc. $NEO Shares Bought by First Light Asset Management LLC - MarketBeat
NeoGenomics Inc. (NEO) Key Financial Ratios – Valuation, Profitability & More - Value Research
NeoGenomics EVP Alicia Olivo Surrenders Shares for Tax Withholding Following Restricted Stock Vesting - Kalkine Media
Bank of New York Mellon Corp Takes Position in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
NeoGenomics Inc. (NEO) Peer Comparison – Compare with Others - Value Research
NeoGenomics Inc. (NEO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail
NeoGenomics Shares Rise After RaDaR ST Assay Gets Expanded Medicare Coverage - marketscreener.com
NeoGenomics Stock Just Turned Its First Profit, Creating an Optimal Entry Point - Yahoo Finance
NeoGenomics gains Medicare coverage for cancer MRD test By Investing.com - Investing.com Canada
NeoGenomics RaDaR ST wins expanded Medicare coverage for immunotherapy response monitoring - Bitget
NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring - Yahoo Finance
NeoGenomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
NeoGenomics (NEO) COO converts 28K stock units into common shares - Stock Titan
NeoGenomics, Inc. (NEO) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
NeoGenomics (NASDAQ:NEO) Healthcare Innovation Gains Attention - Kalkine Media
NeoGenomics (NASDAQ:NEO) Reaches New 12-Month HighHere's Why - MarketBeat
Neogenomics stock hits 52-week high at 16.93 USD By Investing.com - Investing.com Nigeria
Neogenomics stock hits 52-week high at 16.93 USD - Investing.com
NeoGenomics, Inc. Revenue Breakdown – NASDAQ:NEO - TradingView
NeoGenomics (NEO) Advances 1.44% to $16.17 as Buyers Hold Above Key SupportPercent Above MA - vinanet.vn
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
Neogenomics Inc (NEO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Aunan Greg D | Chief Accounting Officer |
Aug 04 '26 |
Sale |
16.07 |
20,000 |
321,400 |
5,153 |
0.99%
0.56%
大文字化:
|
ボリューム (24 時間):